Related Experiment Video
Updated: Aug 18, 2025

06:56
Human Fetal Blood Flow Quantification with Magnetic Resonance Imaging and Motion Compensation
Published on: January 7, 2021
2.5K
Particle Tracing Based on 4D Flow Magnetic Resonance Imaging: A Systematic Review into Methods, Applications, and
Paul R Roos1, Friso M Rijnberg2, Jos J M Westenberg1
1Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Journal of Magnetic Resonance Imaging : JMRI
|December 9, 2022
Summary
Particle tracing with four-dimensional Flow MRI (4D Flow MRI) offers valuable insights into blood flow patterns in cardiovascular diseases. Further research is needed to fully establish its clinical utility across various conditions.
Area of Science:
- Cardiovascular Imaging
- Biomedical Engineering
- Medical Physics
Background:
- Four-dimensional Flow MRI (4D Flow MRI) is a postprocessing technique used to analyze blood flow dynamics.
- Particle tracing, applied to 4D Flow MRI data, provides quantitative and qualitative insights into temporally evolving blood flow patterns.
Approach:
- A systematic review was conducted to identify and synthesize methods, clinical applications, and developments of 4D Flow MRI-based particle tracing.
- Two focused searches on the PubMed database were performed, supplemented by additional literature searches.
- Data extracted included particle tracing methodologies, clinical applications, and reported clinical value.
Key Points:
- Most methods utilize adaptive timesteps, fourth-order Runge-Kutta integration, and linear time interpolation.
- Particle tracing has been applied across diverse cardiovascular anatomies, including heart chambers, aorta, and cerebral vasculature.
- Applications are categorized into intravascular, intracardiac, flow stasis, and research-oriented uses.
Conclusions:
- 4D Flow MRI-based particle tracing provides unique insights into blood flow in cardiovascular diseases.
- The technique's quality is highly dependent on MRI data quality.
- Additional studies are necessary to fully evaluate the clinical value of particle tracing for specific cardiovascular diseases.

